United Nations, New York, 22 July 2009 – Office of the Spokesperson for the Secretary-General. Mother-to-child HIV transmission rates can be dramatically cut with the administration of a cocktail of antiretroviral (ARV) drugs over a longer period of time to pregnant and breastfeeding women, the Joint United Nations Programme on HIV/AIDS (UNAIDS) announced today. Newborn babies are over 40 per cent less likely to become infected with the virus if HIV-positive pregnant women take a combination of three ARV drugs from the last trimester of pregnancy until six months into breastfeeding, rather than a short course of drugs that ends at delivery, according to a new study led by the World Health Organization (WHO). The study named Kesho Bora, which means a better future in Swahili involved 1140 women from Burkina Faso, Kenya and South Africa and showed that a significant reduction can be achieved in many pregnant women with a lowered immune cell count.
Related posts:
- New Directions For Women | Drug Treatment | Alcohol Treatment | Women | Pregnant Women | Children
- Drugs During Pregnancy and Lactation, Second Edition: Treatment Options and Risk Assessment (Schaefer, Drugs During Pregnancy and Lactation)
- Q&A: Do home drug test kits really hold up in family court?
- Drug and Alcohol Treatment Program Tour
- Gastric Cancer – Global Drug Forecasts and Treatment Analysis to 2020 – Volume I 2011
- Kaplan and Sadock’s Pocket Handbook of Psychiatric Drug Treatment
- Drug Treatment – Alcohol Treatment – Brighton Hospital
- Why should a woman stop drinking alcohol or undergo alcohol treatment first before deciding to get pregnant?
- Drug Treatment Houston
- Q&A: Are there programs available for the people of Lewiston, ME who are seeking drug treatment?
Posted in 
Tags: